BUSINESS
What is a sero-survey and will it help in the fight against COVID-19?
ICMR had earlier claimed that the test kit has an impressive 100 percent specificity and 98 percent sensitivity.
BUSINESS
PPE manufacturers complain about lack of clarity on standardisation guidelines
"Currently, India follows a 'one-size-fits-all' criteria for coveralls in contrast to the category-wise standardisation followed in other countries," said Karan Bose, Managing Director, Hula Global.
BUSINESS
COVID-19 testing utilisation in private labs below 30%: Study
The study surveyed 50 private laboratories across 13 Indian states to explore ways to enhance testing in private sector labs.
BUSINESS
Govt rolls out fiscal incentives for bulk drug makers to reduce dependence on China
The government expects the scheme to benefit up to 136 manufacturing units.
BUSINESS
Stent maker SMT acquires Vascular Concepts to foray into transcatheter heart valves
Vascular Concepts has developed and launched the Hydra transcatheter aortic valve system, which received Indian regulatory approval in 2020
BUSINESS
French optical maker Essilor bets on business rebound as India eases COVID-19 lockdown
Along with its associate companies, Essilor employs 5,000 people in India and exports optical products to Europe, the US and Canada.
BUSINESS
Biocon gets drug regulator's nod for CytoSorb device to treat critical COVID-19 patients
"The goal of CytoSorb therapy is to reduce cytokine storm and the deadly inflammatory response through blood purification so that this injury may be mitigated or prevented," the company added.
BUSINESS
COVID-19: ICMR refuses to budge on HCQ use; AIIMS doctors back govt stance
Critics point out that ICMR should have been more transparent by providing full data of its observational studies.
CORONAVIRUS
Coronavirus pandemic | Experts seek more clinical evidence as India expands prophylactic use of HCQ
The National Task force for COVID-19, constituted by ICMR, has reviewed the use of HCQ for prophylaxis of SARS-CoV-2 infections for high-risk population based on emerging evidence on its safety and efficacy.
BUSINESS
Coronavirus Lockdown 4.0 | Here is a list of essential medical gadgets to have at home
These gadgets can help keep track of your health and minimise risk of health-related complications. They will help cut frequency of your visits to diagnostic labs and doctors
BUSINESS
Johnson & Johnson baby talc powder: Should North American market pullout be a concern for Indian authorities?
The company said it decision to discontinue is part of a broader portfolio assessment related to COVID-19 prioritisation, and has nothing to do with safety of the product.
BUSINESS
Working on products related to COVID-19: Dr Reddy's
GV Prasad, Co-Chairman and MD of Dr Reddy's, said the company is working with partners on these drugs but did not divulge details.
BUSINESS
Biocon Biologics on track to achieve $1 billion FY22 revenue target: CEO Christiane Hamacher
"We currently have adequate capacity to cater to increased market share or to anticipated regulatory approvals of our biosimilars in various jurisdictions," said Christiane Hamacher, CEO and Managing Director of Biocon Biologics in an email interview to Moneycontrol
CORONAVIRUS
Explained: Is Moderna's vaccine for COVID-19 worth the hype?
Though Moderna is yet to commercially launch a single vaccine or drug, its market valuation has soared to $29 billion, zooming by 254%, since the COVID-19 outbreak.
BUSINESS
Cipla expects margin, RoCE expansion in FY21; ability to supply crucial, says CFO
"In pharma, demand is there, but growth depends more on our ability to supply," Upadhye said in the context of COVID-19 pandemic that's threatening operations. The lockdown had impacted sales of Rs 200 crore for Q4FY20
BUSINESS
Explained | What is human challenge trial and how it can help develop COVID-19 vaccine faster
Advocacy group 1DaySooner claims that by advancing a vaccine by 3 months would save over half a million lives.
BUSINESS
COVID-19 impact | High demand for face masks, PPEs driving growth in companies like Garware
"Starting from the month of March, we have seen a 40 percent surge in our supplies to the medical and hygiene industry, which will continue till June 2020 and beyond as well," said Anand Kulkarni, Vice President of Global Sales, Garware Bestretch.
BUSINESS
Pune-based NovaLead gets DCGI nod to test old drug against COVID-19
This approved drug codenamed NLP21 is in human use for several years for its original use without any side effects of concern.
BUSINESS
Coronavirus pandemic | Demand for API specialists, regulatory experts rises in pharma sector
There is a dearth of quality talent in India even as pharma firms are ramping up to meet demand due to the coronavirus outbreak
BUSINESS
Explainer: What makes Gilead issue voluntary licenses for COVID-19 drug to generic companies
Remdesivir has been issued an Emergency Use Authorization (EUA) by USFDA to treat COVID-19 patients.
BUSINESS
COVID-19 treatment | Gilead signs pact with Cipla, Jubilant and Hetero to manufacture, distribute Remdesivir in 127 countries
The licenses are royalty-free until the World Health Organization (WHO) declares the end of the Public Health Emergency of International Concern regarding COVID-19, or until a pharmaceutical product other than remdesivir or a vaccine is approved to treat or prevent COVID-19, whichever is earlier.
BUSINESS
Explainer: What is ELISA test, will it help us scale up COVID-19 surveillance efforts?
The ICMR will be soon deploying ELISA testing for conducting a national-level surveillance study on the prevalence of COVID-19.
BUSINESS
Liquidity a big challenge, expect economic recovery to take 2-3 quarters: Ajay Piramal
"It will take at least two or three quarters to reach the December 2019 GDP level of 4.7 percent. This crisis is going to impact all industries, with liquidity being one of the big challenges," Piramal said in the post earnings media call.
BUSINESS
COVID-19 treatment: Jaipur's SMS Medical College says plasma therapy shows promise
SMS medical team members to submit data to ICMR once they complete plasma therapy on 20 patients.
